Novel Immunotherapy Combo for Lung Cancer Shows Promise in Early Trial – Specialty Pharmacy Times
|
Novel Immunotherapy Combo for Lung Cancer Shows Promise in Early Trial
Specialty Pharmacy Times A novel immunotherapy combination may help patients with non-small cell lung cancer who do not benefit from checkpoint therapy alone, according to a new study published in The Lancet Oncology. Immunologist John Wrangle, MD, of the Hollings Cancer … |
